Dichloroacetate as a novel pharmaceutical treatment for cancer-related fatigue in melanoma.

MLA

Xinyi Zhang, et al. “Dichloroacetate as a Novel Pharmaceutical Treatment for Cancer-Related Fatigue in Melanoma.” American Journal of Physiology: Endocrinology & Metabolism, vol. 325, no. 4, Oct. 2023, pp. e363–75. EBSCOhost, https://doi.org/10.1152/ajpendo.00105.2023.

APA

Xinyi Zhang, Lee, W. D., Leitner, B. P., Wanling Zhu, Fosam, A., Zongyu Li, Gaspar, R. C., Halberstam, A. A., Robles, B., Rabinowitz, J. D., & Perry, R. J. (2023). Dichloroacetate as a novel pharmaceutical treatment for cancer-related fatigue in melanoma. American Journal of Physiology: Endocrinology & Metabolism, 325(4), e363–e375. https://doi.org/10.1152/ajpendo.00105.2023

Chicago

Xinyi Zhang, Won D. Lee, Brooks P. Leitner, Wanling Zhu, Andin Fosam, Zongyu Li, Rafael C. Gaspar, et al. 2023. “Dichloroacetate as a Novel Pharmaceutical Treatment for Cancer-Related Fatigue in Melanoma.” American Journal of Physiology: Endocrinology & Metabolism 325 (4): e363–75. doi:10.1152/ajpendo.00105.2023.